• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:顺铂诱导的溶血性尿毒症综合征。

Case report: cisplatin-induced hemolytic uremic syndrome.

作者信息

Khansur T, Kennedy A

机构信息

Department of Veterans Affairs, Medical Center, Jackson, MS 39216.

出版信息

Am J Med Sci. 1991 Jun;301(6):390-2. doi: 10.1097/00000441-199106000-00006.

DOI:10.1097/00000441-199106000-00006
PMID:1645502
Abstract

Two patients developed noncardiogenic pulmonary edema (NCPE), following red blood cell transfusion in a setting of acute cisplatin nephropathy. One manifested the full picture of hemolytic uremic syndrome, the other had transient features following blood transfusion. We further reviewed the clinical records on blood transfusion for all patients with cisplatin nephropathy. A third case of (NCPE) was identified in a patient with acute renal dysfunction. However, none of the 16 patients with cisplatin-induced, mild stable chronic renal impairment had pulmonary dysfunction or other laboratory evidence for microangiopathy following transfusion. Hemolytic uremic syndrome may be a rare manifestation of cisplatin toxicity. Caution is indicated in transfusing patients with acute platinum nephropathy even in the absence of overt microangiopathy. The pathogenesis of this syndrome and the cause for NCPE is unclear. The literature is reviewed and discussed.

摘要

两名急性顺铂肾病患者在输注红细胞后发生了非心源性肺水肿(NCPE)。其中一名表现出溶血尿毒综合征的全貌,另一名在输血后有短暂症状。我们进一步查阅了所有顺铂肾病患者的输血临床记录。在一名急性肾功能不全患者中发现了第三例(NCPE)。然而,16例顺铂诱导的轻度稳定慢性肾功能损害患者在输血后均无肺功能障碍或其他微血管病的实验室证据。溶血尿毒综合征可能是顺铂毒性的一种罕见表现。即使在没有明显微血管病的情况下,给急性铂肾病患者输血时也应谨慎。该综合征的发病机制及NCPE的病因尚不清楚。本文对相关文献进行了综述和讨论。

相似文献

1
Case report: cisplatin-induced hemolytic uremic syndrome.病例报告:顺铂诱导的溶血性尿毒症综合征。
Am J Med Sci. 1991 Jun;301(6):390-2. doi: 10.1097/00000441-199106000-00006.
2
[The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].顺铂和依托泊苷用于原发性肺癌化疗的疗效与副作用
Gan To Kagaku Ryoho. 1991 May;18(6):1003-6.
3
Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.顺铂、博来霉素和长春新碱化疗后发生的溶血性尿毒症综合征:1例报告并文献复习
Ren Fail. 1989;11(2-3):133-7. doi: 10.3109/08860228909066955.
4
Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.顺铂相关的溶血尿毒综合征。用葡萄球菌蛋白A柱成功治疗。
Cancer. 1989 Oct 1;64(7):1400-3. doi: 10.1002/1097-0142(19891001)64:7<1400::aid-cncr2820640705>3.0.co;2-n.
5
Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.顺铂与依托泊苷联合治疗支气管癌
Chemioterapia. 1984 Feb;3(1):16-8.
6
[Chemotherapy-associated hemolytic uremic syndrome--a case report].[化疗相关的溶血性尿毒症综合征——一例报告]
Gan To Kagaku Ryoho. 1992 Sep;19(11):1927-9.
7
[The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].顺铂、长春新碱、阿霉素和依托泊苷联合化疗(德岛方案:T-CODE)治疗肺癌的疗效
Gan To Kagaku Ryoho. 1992 Aug;19(9):1403-5.
8
[Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
Gan To Kagaku Ryoho. 1992 Jan;19(1):115-8.
9
Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.顺铂、依托泊苷和丝裂霉素治疗非小细胞肺癌的初步研究
Cancer. 1986 Sep 1;58(5):1018-9. doi: 10.1002/1097-0142(19860901)58:5<1018::aid-cncr2820580505>3.0.co;2-q.
10
Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Oncology. 2001;61(2):143-6. doi: 10.1159/000055365.

引用本文的文献

1
Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis.日本人群中吉西他滨诱导的血栓性微血管病的发病时间:病例系列和大规模药物警戒分析。
Cancer Diagn Progn. 2023 Jan 3;3(1):115-123. doi: 10.21873/cdp.10188. eCollection 2023 Jan-Feb.
2
Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.小儿肿瘤肾脏病学:是时候广而告之了:第一部分:恶性肿瘤患儿的早期肾脏受累情况
Pediatr Nephrol. 2021 Aug;36(8):2227-2255. doi: 10.1007/s00467-020-04800-3. Epub 2020 Nov 27.